Literature DB >> 7064841

Response of plasma norepinephrine and epinephrine to dynamic exercise in patients with congestive heart failure.

G S Francis, S R Goldsmith, S M Ziesche, J N Cohn.   

Abstract

The activity of the sympathetic nervous system is increased at rest in patients with congestive heart failure. To determine whether this augmentation is carried over during dynamic upright exercise, 14 patients with congestive heart failure were stressed maximally during upright bicycle ergometry. Plasma norepinephrine and epinephrine levels were measured in the basal upright (sitting) posture before and during maximal exercise. The results were compared with those in six healthy control subjects before and during maximal exercise. Plasma norepinephrine increased during exercise from a mean (+/- standard error of the mean) of 650 +/- 95 to 1,721 +/- pg/ml in the group with heart failure. This increase was significantly less (p less than 0.001) than that in the control group (from 318 +/- 36 to 3,230 +/- 418 pg/ml). However, for equivalent levels of total body oxygen consumption (VO2), the group with heart failure had higher levels of plasma norepinephrine than the control group. Plasma epinephrine was similar in the two groups in the basal upright position (92 +/- 18 and 92 +/- 26 pg/ml), but it increased more during exercise in the normal subjects (743 +/- 210 pg/ml) than in the group with heart failure (167 +/- 67 pg/ml) (p less than 0.001). The percent increase in norepinephrine correlated with the percent change in VO2 in the group with heart failure (r = 0.62, p less than 0.02), but the percent change in epinephrine did not. There is, therefore, a disturbance in the sympathetic nervous system during exercise in patients with congestive heart failure. Although norepinephrine increases in such patients to a greater extent than in normal subjects at lower levels of exercise, the extremely high levels of norepinephrine and epinephrine generated by normal subjects during maximal upright exercise do not occur in patients with heart failure.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7064841     DOI: 10.1016/0002-9149(82)90039-x

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  29 in total

1.  Forearm vasoconstriction during dynamic leg exercise in patients with chronic heart failure.

Authors:  J J Atherton; L G Dryburgh; H L Thomson; T D Moore; K N Wright; G W Muehle; L E Fitzpatrick; M P Frenneaux
Journal:  Heart Vessels       Date:  1998       Impact factor: 2.037

Review 2.  Therapy of idiopathic dilated cardiomyopathy with chronic beta-adrenergic blockade.

Authors:  E M Gilbert; J B O'Connell; M R Bristow
Journal:  Heart Vessels Suppl       Date:  1991

3.  Skeletal muscle glycogen depletion during submaximal exercise in rats with chronic heart failure.

Authors:  T I Musch; M R Ghaul; V Tranchitella; R Zelis
Journal:  Basic Res Cardiol       Date:  1990 Nov-Dec       Impact factor: 17.165

4.  Neuroendocrine response to standing and mild exercise in patients with untreated severe congestive heart failure and chronic constrictive pericarditis.

Authors:  R Ferrari; I S Anand; C Ceconi; F De Giuli; P A Poole-Wilson; P Harris
Journal:  Heart       Date:  1996-07       Impact factor: 5.994

5.  The deubiquitinase ubiquitin-specific protease 20 is a positive modulator of myocardial β1-adrenergic receptor expression and signaling.

Authors:  Samuel Mon-Wei Yu; Pierre-Yves Jean-Charles; Dennis M Abraham; Suneet Kaur; Clarice Gareri; Lan Mao; Howard A Rockman; Sudha K Shenoy
Journal:  J Biol Chem       Date:  2018-12-11       Impact factor: 5.157

6.  Selective regulation of beta 1- and beta 2-adrenoceptors in the human heart by chronic beta-adrenoceptor antagonist treatment.

Authors:  M C Michel; A Pingsmann; J J Beckeringh; H R Zerkowski; N Doetsch; O E Brodde
Journal:  Br J Pharmacol       Date:  1988-07       Impact factor: 8.739

Review 7.  Beyond ejection fraction.

Authors:  A Marmor; D Jain; B Zaret
Journal:  J Nucl Cardiol       Date:  1994 Sep-Oct       Impact factor: 5.952

8.  Do human cardiac beta-2 adrenoceptors play a (patho)physiological role in regulation of heart rate and/or contractility?

Authors:  O E Brodde; H R Zerkowski
Journal:  Basic Res Cardiol       Date:  1989       Impact factor: 17.165

Review 9.  Pathophysiology of exercise heart rate recovery: a comprehensive analysis.

Authors:  Gordon L Pierpont; Selcuk Adabag; Demetri Yannopoulos
Journal:  Ann Noninvasive Electrocardiol       Date:  2013-03       Impact factor: 1.468

10.  Oxygen uptake kinetics in chronic heart failure: clinical and physiological aspects.

Authors:  H M C Kemps; G Schep; J Hoogsteen; E J M Thijssen; W R De Vries; M Zonderland; P Doevendans
Journal:  Neth Heart J       Date:  2009-06       Impact factor: 2.380

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.